Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement Regarding Share Price Movement

19 Mar 2020 07:00

RNS Number : 7092G
Arden Partners plc
19 March 2020
 

Arden Partners plc

("Arden" or the "Company")

 

Statement Regarding Share Price Movement

Arden (AIM: ARDN) has noted the recent downward movement in its share price, in particular on 18 March 2020, on very small volumes.

The Board understands the current volatile nature of the stock market and the impact of this on relatively illiquid stocks, but it wishes to advise shareholders that, as at 29 February 2020, the unaudited net asset value of the Company was £5.6m (equating to a net asset value per share of 19.2 pence).

The Company's preliminary results statement (released on 3 February 2020), highlighted that it was well capitalised as at its latest year end and the Board confirms that it remains so.

The Board's priority will be to protect the Company's balance sheet whilst remaining focussed on delivering its stated growth strategy and on servicing Arden's clients' needs. This remains the case despite the current difficult market conditions.

For further enquiries:

Arden Partners plc

020 7614 5900

Steve Douglas - Group Finance Director

 

GCA Altium Limited

 

020 7484 4040

Sam Fuller / Tim Richardson

 

Notes for editors

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SPMEANDPFALEEFA
Date   Source Headline
28th Apr 202210:15 amRNSOffer Update - Scheme of Arrangement - Effective
28th Apr 20227:30 amRNSSuspension - Arden Partners PLC
28th Apr 20227:00 amRNSNomad register change - Arden Partners Plc
27th Apr 20224:30 pmRNSOffer Update-Court Sanction, Scheme of Arrangement
27th Apr 20224:30 pmRNSOffer Update - Court Sanction of Scheme
21st Apr 20225:30 pmRNSInce Group
19th Apr 20222:00 pmRNSOffer Update – Extension of FCA approval
19th Apr 20222:00 pmRNSExtension of FCA Change of Control Approval
14th Apr 20227:00 amRNSOffer Update - Timetable for completion of Scheme
14th Apr 20227:00 amRNSOffer Update - Timetable for Completion of Scheme
12th Apr 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20227:00 amRNSOffer update – Waiver of NOMAD condition
11th Apr 20227:00 amRNSOffer Update - Waiver of NOMAD Condition
8th Apr 20222:19 pmRNSPublication of Annual Report and Notice of AGM
7th Apr 20222:18 pmRNSHolding(s) in Company
7th Apr 20229:33 amRNSUpdate regarding the NOMAD condition
7th Apr 20227:00 amRNSUpdate Regarding the Nomad Condition
6th Apr 202211:41 amRNSForm 8.3 - Arden Partners plc
5th Apr 20227:00 amRNSAudited Results for the Year Ended 31 October 2021
18th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI) - AssetCo PLC
14th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202210:20 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:48 amRNSForm 8.3 - Ince Group PLC
7th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 20221:03 pmRNSForm 8.5 (EPT/NON-RI)
2nd Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20221:00 pmRNSForm 8.5 (EPT/NON-RI)
26th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20227:00 amRNSApproval of the FCA condition
21st Jan 20227:00 amRNSFCA Approval of the Change of Control
20th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20224:30 pmRNSResults of Arden court meeting & general meeting
19th Jan 20224:24 pmRNSResults of Court Meeting and General Meeting
18th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20212:30 pmRNSPublication of Scheme Document
15th Dec 20217:00 amRNSExtension Of Irrevocable Undertakings
8th Dec 20218:00 amRNSExtension Of Irrevocable Undertakings
1st Dec 20212:03 pmRNSForm 8 (DD) - The Ince Group plc
30th Nov 202111:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.